Reversible Secondary Myelofibrosis or Clonal Myeloproliferative Disorder

Clinical trial NCT00722254 · TERMINATED

Trial details

NCT number: NCT00722254
Sponsor: University of Utah
Status: TERMINATED
Study type: OBSERVATIONAL

Primary Myelofibrosis Primary Pulmonary Hypertension Secondary Myelofibrosis Pulmonary Arterial Hypertension

Start date: 2006-06-01
Primary completion: 2009-02-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.